| Literature DB >> 15102905 |
Isabell Greeve1, Doris Kretzschmar, Jakob-Andreas Tschäpe, Anika Beyn, Claire Brellinger, Michaela Schweizer, Roger M Nitsch, Rita Reifegerste.
Abstract
Beta-amyloid peptides that are cleaved from the amyloid precursor protein (APP) play a critical role in Alzheimer's disease (AD) pathophysiology. Here, we show that in Drosophila, the targeted expression of the key genes of AD, APP, the beta-site APP-cleaving enzyme BACE, and the presenilins led to the generation of beta-amyloid plaques and age-dependent neurodegeneration as well as to semilethality, a shortened life span, and defects in wing vein development. Genetic manipulations or pharmacological treatments with secretase inhibitors influenced the activity of the APP-processing proteases and modulated the severity of the phenotypes. This invertebrate model of amyloid plaque pathology demonstrates Abeta-induced neurodegeneration as a basic biological principle and may allow additional genetic analyses of the underlying molecular pathways.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15102905 PMCID: PMC6729409 DOI: 10.1523/JNEUROSCI.0283-04.2004
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167